HRT Financial’s NextCure NXTC Stock Holding History

HRT Financial’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,927	Closed	-$236K	–	3799
2021 Q3	$236K	Sell	2,927 -1,622	-36%	-$142K	﹤0.01%	2570
2021 Q2	$438K	Buy	4,549 +1,460	+47%	+$149K	﹤0.01%	1895
2021 Q1	$371K	Buy	+3,089	New	+$447K	﹤0.01%	1989

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HRT Financial's NXTC Position: Q4 2021 in Review

HRT Financial sold out of NextCure (NXTC) in Q4 2021, closing a stake of 2,927 shares — an estimated $236K sold.

HRT Financial first reported a position in NXTC in Q1 2021 and held it in 3 quarters. The position peaked at $438K in Q2 2021. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

HRT Financial reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
HRT Financial sold 2,927 NextCure shares in Q4 2021, an estimated $236K.
HRT Financial first reported a position in NextCure in Q1 2021 and held it in 3 quarters.
HRT Financial's NextCure position peaked at $438K in Q2 2021.
71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.